agilon health, inc. (AGL) Fair Value 2026

AGL · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.9 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (32/100)

Quick Summary — As of 2026-08-27, agilon health, inc. (AGL) trades at $94.18, versus a $41.75 median fair value across its 2 active models — 55.7% below the current price. QOC: 5.9/10. Value Trap Risk: 32/100 (LOW). 2/13 models active.

Key Facts

Ticker
AGL
Price
$94.18
Quality Score
5.9/10
Value Trap Risk
32/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is agilon health, inc. (AGL) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, agilon health, inc. (AGL) appears overvalued as of : the median of 2 independent fair value estimates is $41.75, 55.7% below the current price of $94.18. Estimates range from $38.81 to $44.69. AGL scores 5.9/10 on fundamental quality and 32/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. AGL’s -55.7% gap is wider than that market norm, and the Medical Care Facilities sector median is -28.6%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy agilon health, inc. Stock in 2026? →

What Fair Value Does Each Model Give AGL?

2 Intrinsic Value Models vs. Current Price ($94.18)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Medium Conviction
 $38.81 -58.8%
Relative · Low Conviction
 $44.69 -52.5%

All Models Active

All 2 models are displayed above.

What Is agilon health, inc. (AGL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, agilon health, inc.'s intrinsic value is estimated at $41.75. Trading at its current price of $94.18, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -55.7%.

What Do the Models Say About AGL?

2 of 13 models are currently active for AGL. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for AGL is $41.75 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does AGL Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, AGL ranks #39 by Quality of Company score. CirclFi's QOC score of 5.9/10 evaluates 32 fundamental signals. A score of 5.9 reflects mixed fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

agilon health, inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is AGL a Value Trap?

CirclFi's Value Trap algorithm assigns AGL a score of 32/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for agilon health, inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, agilon health, inc. scores 5.9 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

Models cluster within a tight range (+6.2% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AGL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across AGL's 2 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy agilon health, inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

SYRASyra Health Corp.QOC 5.9GBCSSelectis Health, Inc.QOC 5.9CCMConcord Medical Services Holdings LimitedQOC 6.1AMSAmerican Shared Hospital ServicesQOC 5.9MCTACharming Medical LimitedQOC 6.1EHSIElite Health Systems Inc.QOC 5.8HLYKHealthLynked Corp.QOC 4.1PNTGThe Pennant Group, Inc.QOC 8.3AUNAAuna SAQOC 7.2ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: SYRA · GBCS · CCM · AMS · MCTA · EHSI · HLYK · PNTG · AUNA · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to AGL?

7 companies across all industries closest to AGL’s Quality of Company score of 5.9/10.

CMCOColumbus McKinnon CorporationQOC 5.9FTCOFortitude Gold CorporationQOC 5.9RYTMRhythm Pharmaceuticals, Inc.QOC 5.9CCGCheche Group Inc.QOC 5.9BRNBarnwell Industries, Inc.QOC 5.9YMTYimutian Inc.QOC 5.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CMCO · FTCO · RYTM · CCG · BRN · YMT · NVDA

Where Does AGL Sit in CirclFi's Medical Care Facilities Rankings?

AGL is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About agilon health, inc.’s Valuation?

What is agilon health, inc.'s intrinsic value in 2026?

CirclFi puts agilon health, inc. (AGL)'s intrinsic value at $41.75 — the median of 2 independent model estimates as of 2026-08-27, ranging from $38.81 to $44.69. The Quality of Company score is 5.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AGL overvalued or undervalued right now?

At $94.18, 0 of 2 active models suggest AGL may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $41.75, 55.7% below the current price of $94.18 — a consensus view that AGL is overvalued. The assessment depends on which methodology best fits agilon health, inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 5.9 mean for AGL?

agilon health, inc.'s QOC of 5.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on AGL?

CirclFi analyzes AGL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is AGL a value trap in 2026?

agilon health, inc.'s Value Trap score is 32/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, agilon health, inc. (AGL) has a median fair value of $41.75 — 55.7% below the current price of $94.18 — as of 2026-08-27.” Source: circlfi.com/stock/AGL/ · Methodology
Primary sources for this AGL valuation
  • Financial statements: agilon health, inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001831097) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for AGL as of ; valuations recomputed .